MRK vs. AMGN
Compare and contrast key facts about Merck & Co., Inc. (MRK) and Amgen Inc. (AMGN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or AMGN.
Correlation
The correlation between MRK and AMGN is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
MRK vs. AMGN - Performance Comparison
Loading data...
Key characteristics
MRK:
-1.35
AMGN:
-0.35
MRK:
-1.84
AMGN:
-0.26
MRK:
0.75
AMGN:
0.97
MRK:
-0.87
AMGN:
-0.35
MRK:
-1.58
AMGN:
-0.74
MRK:
22.81%
AMGN:
10.67%
MRK:
27.04%
AMGN:
25.21%
MRK:
-68.62%
AMGN:
-78.02%
MRK:
-38.09%
AMGN:
-17.25%
Fundamentals
MRK:
$201.96B
AMGN:
$147.74B
MRK:
$6.88
AMGN:
$10.98
MRK:
11.69
AMGN:
25.02
MRK:
0.73
AMGN:
0.93
MRK:
3.16
AMGN:
4.33
MRK:
4.11
AMGN:
23.90
MRK:
$63.92B
AMGN:
$34.13B
MRK:
$51.75B
AMGN:
$21.50B
MRK:
$27.30B
AMGN:
$12.38B
Returns By Period
In the year-to-date period, MRK achieves a -18.45% return, which is significantly lower than AMGN's 6.27% return. Over the past 10 years, MRK has underperformed AMGN with an annualized return of 6.65%, while AMGN has yielded a comparatively higher 8.45% annualized return.
MRK
-18.45%
1.58%
-18.82%
-36.33%
4.78%
6.65%
AMGN
6.27%
-3.92%
-13.24%
-8.71%
6.26%
8.45%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. AMGN — Risk-Adjusted Performance Rank
MRK
AMGN
MRK vs. AMGN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MRK vs. AMGN - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 3.93%, more than AMGN's 3.32% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 3.93% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
AMGN Amgen Inc. | 3.32% | 3.45% | 2.96% | 2.95% | 3.13% | 2.78% | 2.41% | 2.71% | 2.65% | 2.74% | 1.95% | 1.53% |
Drawdowns
MRK vs. AMGN - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, smaller than the maximum AMGN drawdown of -78.02%. Use the drawdown chart below to compare losses from any high point for MRK and AMGN. For additional features, visit the drawdowns tool.
Loading data...
Volatility
MRK vs. AMGN - Volatility Comparison
Merck & Co., Inc. (MRK) has a higher volatility of 10.45% compared to Amgen Inc. (AMGN) at 9.42%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than AMGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MRK vs. AMGN - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MRK vs. AMGN - Profitability Comparison
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
AMGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Amgen Inc. reported a gross profit of 5.18B and revenue of 8.15B. Therefore, the gross margin over that period was 63.6%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
AMGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Amgen Inc. reported an operating income of 1.18B and revenue of 8.15B, resulting in an operating margin of 14.5%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.
AMGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Amgen Inc. reported a net income of 1.73B and revenue of 8.15B, resulting in a net margin of 21.2%.